Search results
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Zacks via Yahoo News· 5 days agoLoss per share estimate for 2025 has narrowed from $2.06 to $2.05. Year to date, RAPT shares have...
NetApp (NTAP) Unveils Advanced Capabilities for Cloud Platforms
Zacks via Yahoo News· 5 days agoWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best...
Is Hodges Small Cap Fund Institutional Class (HDSIX) a Strong Mutual Fund Pick Right Now?
Zacks via Yahoo News· 6 days agoZacks provides a full suite of tools to help you analyze your portfolio - both funds and stocks - in...
Select Medical (SEM) Expands Rehabilitation Services in Central PA
Zacks via Yahoo News· 5 days agoSelect Medical (SEM) and UPMC unveil a 20-bed satellite facility of Helen M. Simpson Rehabilitation...
Eli Lilly (LLY) to Buy Morphic for $3.2B, Boost IBD Presence
Zacks via Yahoo News· 7 days agoEli Lilly's (LLY) acquisition of Morphic (MORF) is set to expand its immunology pipeline by adding...
Zevra (ZVRA) Rises on Update on Niemann-Pick Disease Type C Drug
Zacks via Yahoo News· 6 days agoThe FDA will meet with its Genetic Metabolic Diseases Advisory Committee to review Zevra's (ZVRA)...
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
Zacks via Yahoo News· 4 days agoVerona Pharma (VRNA) surges on the recent FDA approval for its lead drug, which is the first inhaled...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo News· 6 days agoWith the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to...
First Solar (FSLR) Rises 33% Year to Date: Should You Buy Now?
Zacks via Yahoo News· 5 days agoFirst Solar (FSLR) rides on enhancing manufacturing capacities and innovating new products, backed...
SpringWorks (SWTX) Rises More Than 40% in a Year: Here's Why
Zacks via Yahoo News· 4 days agoSpringWorks' (SWTX) Ogsiveo is the first drug approved by the FDA to treat desmoid tumors. The...